Jane Schmidt
About Jane Schmidt
Jane Schmidt is the Director of Clinical Operations at BridgeBio, a position she has held since 2023. With extensive experience in clinical operations and research, she has worked at several prominent companies in the biotechnology and pharmaceutical sectors.
Current Role at BridgeBio
Jane Schmidt has been serving as the Director of Clinical Operations at BridgeBio since 2023. In this role, she oversees clinical operations, ensuring that clinical trials are conducted efficiently and in compliance with regulatory standards. Her responsibilities include managing clinical trial processes, coordinating with various teams, and facilitating communication between stakeholders. This position highlights her extensive experience in clinical operations within the biotechnology sector.
Previous Experience in Clinical Operations
Before joining BridgeBio, Jane Schmidt held various positions in clinical operations across several organizations. She worked as a Senior Clinical Trial Manager at Myovant Sciences from 2018 to 2022, where she managed multiple clinical trials. Prior to that, she served as a Clinical Trial Manager at Myovant Sciences from 2016 to 2018. Her earlier roles include Clinical Research Associate I and Clinical Study Assistant at Medivation, and Research Associate III at Seattle Genetics.
Educational Background
Jane Schmidt studied at London Metropolitan University, where she earned a BSc with 1st Class Honours in Applied Chemistry. She furthered her education at UC Berkeley Extension, obtaining a Professional Certificate in Clinical Research Conduct and Management in 2012. This educational foundation supports her expertise in clinical operations and research management.
Career Timeline
Jane Schmidt's career spans over two decades in the biotechnology and pharmaceutical industries. She began her career as a Senior Research Associate at Millennium Pharmaceuticals from 2002 to 2005. Following this, she worked at Theravance as an Associate Scientist from 2007 to 2010. Her career includes significant roles at Myovant Sciences, Medivation, and Seattle Genetics, showcasing her progression in clinical operations and research.